Penumbra Management

Management Kriterienprüfungen 4/4

Penumbra CEO ist Adam Elsesser , ernannt in Jun 2004, hat eine Amtszeit von 20.42 Jahren. Die jährliche Gesamtvergütung beträgt $601.62K , bestehend aus 99.7% Gehalt und 0.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 2.27% der Aktien des Unternehmens, im Wert von $208.72M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.5 Jahre bzw. 8.7 Jahre.

Wichtige Informationen

Adam Elsesser

Geschäftsführender

US$601.6k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	99.7%
Amtszeit als Geschäftsführer	20.4yrs
Eigentum des Geschäftsführers	2.3%
Durchschnittliche Amtszeit des Managements	4.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	8.7yrs

Jüngste Management Updates

Recent updates

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 11

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Jun 19

Penumbra: Appeal Improves As Operating Leverage Continues

May 30

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Apr 12

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Mar 21

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Jan 23

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Nov 16

Penumbra: Appeal Improves, Just Not Appealing Yet

Oct 16

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Oct 05

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

Sep 01

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Aug 15

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Jun 28

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Jun 02

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Feb 23

Penumbra Riding Higher On Upcoming Launches And Rerating

Jan 12

Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy

Nov 03

Penumbra cut to Neutral at Citi on macro concerns

Oct 05

Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan

Sep 22

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Adam Elsesser im Vergleich zu den Einnahmen von Penumbra verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Sep 30 2024	n/a	n/a	US$35m
Jun 30 2024	n/a	n/a	US$14m
Mar 31 2024	n/a	n/a	US$93m
Dec 31 2023	US$602k	US$600k	US$91m
Sep 30 2023	n/a	n/a	US$41m
Jun 30 2023	n/a	n/a	US$29m
Mar 31 2023	n/a	n/a	US$6m
Dec 31 2022	US$602k	US$600k	-US$2m
Sep 30 2022	n/a	n/a	-US$31m
Jun 30 2022	n/a	n/a	-US$19m
Mar 31 2022	n/a	n/a	-US$6m
Dec 31 2021	US$498k	US$496k	US$5m
Sep 30 2021	n/a	n/a	US$34m
Jun 30 2021	n/a	n/a	US$16m
Mar 31 2021	n/a	n/a	-US$5m
Dec 31 2020	US$219k	US$217k	-US$16m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	US$11m
Mar 31 2020	n/a	n/a	US$39m
Dec 31 2019	US$727k	US$725k	US$48m
Sep 30 2019	n/a	n/a	US$45m
Jun 30 2019	n/a	n/a	US$15m
Mar 31 2019	n/a	n/a	US$12m
Dec 31 2018	US$727k	US$725k	US$7m
Sep 30 2018	n/a	n/a	US$9m
Jun 30 2018	n/a	n/a	US$28m
Mar 31 2018	n/a	n/a	US$13m
Dec 31 2017	US$727k	US$725k	US$5m

Vergütung im Vergleich zum Markt: AdamDie Gesamtvergütung ($USD601.62K) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD7.94M).

Entschädigung vs. Einkommen: AdamDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Adam Elsesser (62 yo)

20.4yrs

Amtszeit

US$601,620

Vergütung

Mr. Adam Elsesser serves as President at Penumbra, Inc. since May 2020. He Co-Founded Penumbra, Inc. in 2004 and has been its Chief Executive Officer and Director since June 2004. Mr. Elsesser has been the...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Adam Elsesser	Co-Founder	20.4yrs	US$601.62k	2.27% $ 208.7m
Arani Bose	Co-Founder & Director	20.4yrs	US$233.99k	0.88% $ 80.7m
Maggie Yuen	Chief Financial Officer	4.9yrs	US$666.04k	0.017% $ 1.5m
Lambert Shiu	Chief Accounting Officer	4.9yrs	US$539.94k	0.041% $ 3.8m
Johanna Roberts	Executive VP	6.2yrs	US$661.89k	0.13% $ 12.2m
Ben Sorci	Executive Vice President of Operations	3.8yrs	keine Daten	keine Daten
Pankaj Tiwari	Executive VP & Chief Information Officer	2.8yrs	keine Daten	keine Daten
Jee Hamlyn-Harris	Investor Relations Officer	no data	keine Daten	keine Daten
Ben Tompkins	Executive Vice President of Development & Compliance	less than a year	keine Daten	keine Daten
Shruthi Narayan	Executive VP & GM of Interventional	1.8yrs	keine Daten	keine Daten
Jason Mills	Executive Vice President of Strategy	4.5yrs	keine Daten	keine Daten
James Benenati	Chief Medical Officer	3.8yrs	keine Daten	keine Daten

4.5yrs

Durchschnittliche Betriebszugehörigkeit

52yo

Durchschnittliches Alter

Erfahrenes Management: PENDas Führungsteam des Unternehmens gilt als erfahren (4.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Adam Elsesser	Co-Founder	20.4yrs	US$601.62k	2.27% $ 208.7m
Arani Bose	Co-Founder & Director	20.4yrs	US$233.99k	0.88% $ 80.7m
Harpreet Grewal	Independent Director	9.6yrs	US$241.49k	0.022% $ 2.0m
Thomas Wilder	Independent Director	7.8yrs	US$258.99k	0.012% $ 1.1m
Don Kassing	Presiding Independent Director	16.8yrs	US$246.49k	0.024% $ 2.2m
Surbhi Sarna	Independent Director	5.3yrs	US$248.99k	0.0064% $ 588.5k
Bridget O'Rourke	Independent Director	7.6yrs	US$263.99k	0.011% $ 1.0m
Janet Leeds	Independent Director	5.8yrs	US$251.49k	0.013% $ 1.2m

8.7yrs

Durchschnittliche Betriebszugehörigkeit

60.5yo

Durchschnittliches Alter

Erfahrener Vorstand: PENDie Vorstandsmitglieder gelten als erfahren (8.7 Jahre durchschnittliche Amtszeit).

Penumbra Management

Management Kriterienprüfungen 4/4

Wichtige Informationen

Jüngste Management Updates

Co-Founder notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Executive VP notifies of intention to sell stock

Recent updates

Co-Founder notifies of intention to sell stock

Consensus EPS estimates fall by 48%

Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Penumbra (NYSE:PEN) May Have Issues Allocating Its Capital

Penumbra, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Executive VP notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Penumbra Grinding Through A Painful Growth Expectations Reset

Penumbra, Inc. (NYSE:PEN) announces an Equity Buyback for $200 million worth of its shares.

Consensus EPS estimates fall by 72%

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Second quarter 2024 earnings: EPS misses analyst expectations

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Penumbra, Inc. to Report Q2, 2024 Results on Jul 30, 2024

Now 21% undervalued after recent price drop

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Penumbra: Appeal Improves As Operating Leverage Continues

Co-Founder notifies of intention to sell stock

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Penumbra, Inc. to Report Q1, 2024 Results on May 07, 2024

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Executive VP notifies of intention to sell stock

Full year 2023 earnings: EPS exceeds analyst expectations

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Penumbra, Inc. to Report Q4, 2023 Results on Feb 22, 2024

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Executive VP notifies of intention to sell stock

Penumbra, Inc. Announces First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash for Treatment of Acute Pulmonary Embolism

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Now 21% undervalued after recent price drop

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Announces Latest STRIKE-PE Data Evaluating Penumbra's Indigo Aspiration System with Lightning

Price target decreased by 8.5% to US$301

Penumbra: Appeal Improves, Just Not Appealing Yet

Co-Founder exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Penumbra, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Co-Founder exercised options and sold US$2.8m worth of stock

Executive VP notifies of intention to sell stock

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Co-Founder notifies of intention to sell stock

Consensus EPS estimates increase by 16%

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Co-Founder exercised options and sold US$3.0m worth of stock

Penumbra, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Co-Founder exercised options and sold US$3.1m worth of stock

Executive VP notifies of intention to sell stock

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Penumbra, Inc. Updates Revenue Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Executive VP exercised options and sold US$154k worth of stock

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Independent Director notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Price target increased by 11% to US$291